Early access programs (EAPs) are adopted by an increasing number of pharma companies in India due to the many benefits offered by such programs. Early access programs (EAPs) in India offer ethical, compliant, and controlled mechanisms of access to investigational medicines outside of the clinical trial space and before the commercial launch of the drug, to those with life-threatening ... https://www.ikrispharmanetwork.com/service-named-patient-management